Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 401Neoplasms 343Prostatic Neoplasms 193Lung Neoplasms 178Colorectal Neoplasms 145Motor Activity 92Pancreatic Neoplasms 73Brain Neoplasms 73Uterine Cervical Neoplasms 72Head and Neck Neoplasms 68Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 61Carcinoma, Hepatocellular 53Rectal Neoplasms 50Colonic Neoplasms 46Glioblastoma 44Anxiety Disorders 43Depression 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Hematologic Neoplasms 38Melanoma 36Glioma 34Disease 34Multiple Myeloma 33Stomach Neoplasms 32Sarcoma 32Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 29

Interventions

Robotic Surgical Procedures 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenomyosis × 90 days × Clear all
NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡